Address	5500 Flatiron Parkway Boulder Colorado 80301 United States
Employees	-
Website	http://www.clovisoncology.com
Updated	07/08/2019
Clovis Oncology, Inc. engages in the acquisition, development, and commercialization of anti-cancer agents. Its marketed product, Rubraca, seeks to treat patients with deleterious BRCA mutation associated advanced ovarian cancer, who have been treated with two or more chemotherapies. It also has product candidates, namely Rociletinib and Lucitanib.